Ligand validation:5A92

CEF: CEFOTAXIME, C3' cleaved, open, bound form

CEF is a Ligand Of Interest in 5A92 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5A92_CEF_A_1295	94%	0%	0.087	0.985	4.62	5.63	12	6	2	0	100%	0.6738
2ZQA_CEF_A_301	71%	3%	0.126	0.948	2.63	3.68	8	3	1	0	100%	0.6923
1IYO_CEF_A_301	61%	6%	0.135	0.925	2.31	2.69	6	6	1	0	100%	1
4KG2_CEF_A_402	85%	1%	0.079	0.945	1.73	5.56	4	5	0	0	100%	1
6P54_CEF_B_601	77%	3%	0.102	0.941	1.74	4.5	3	4	0	0	100%	1
6Z23_CEF_A_308	73%	2%	0.117	0.944	3.7	3.35	12	6	1	0	100%	0.49
7RPG_CEF_A_305	71%	2%	0.118	0.94	2.11	4.42	7	6	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.